These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9394623)

  • 1. Calpains: intact and active?
    Johnson GV; Guttmann RP
    Bioessays; 1997 Nov; 19(11):1011-8. PubMed ID: 9394623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpains: enzymes of vision?
    Biswas S; Harris F; Dennison S; Singh JP; Phoenix D
    Med Sci Monit; 2005 Sep; 11(9):RA301-10. PubMed ID: 16127377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent activation of Gsalpha through limited proteolysis by calpain.
    Sato-Kusubata K; Yajima Y; Kawashima S
    Biochem J; 2000 May; 347 Pt 3(Pt 3):733-40. PubMed ID: 10769177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the calpain autoproteolysis by calpastatin and phospholipids.
    Melloni E; Michetti M; Salamino F; Minafra R; Pontremoli S
    Biochem Biophys Res Commun; 1996 Dec; 229(1):193-7. PubMed ID: 8954105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for possible calcium-induced activation mechanisms of calpains.
    Reverter D; Strobl S; Fernandez-Catalan C; Sorimachi H; Suzuki K; Bode W
    Biol Chem; 2001 May; 382(5):753-66. PubMed ID: 11517928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical properties of lens-specific calpain Lp85.
    Shih M; Ma H; Nakajima E; David LL; Azuma M; Shearer TR
    Exp Eye Res; 2006 Jan; 82(1):146-52. PubMed ID: 16054132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?
    Goll DE; Thompson VF; Taylor RG; Zalewska T
    Bioessays; 1992 Aug; 14(8):549-56. PubMed ID: 1365908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic processing of human profilaggrin by active mu-calpain.
    Yamazaki M; Ishidoh K; Suga Y; Saido TC; Kawashima S; Suzuki K; Kominami E; Ogawa H
    Biochem Biophys Res Commun; 1997 Jun; 235(3):652-6. PubMed ID: 9207214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of the calpain family: new aspects.
    Saez ME; Ramirez-Lorca R; Moron FJ; Ruiz A
    Drug Discov Today; 2006 Oct; 11(19-20):917-23. PubMed ID: 16997142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-dependent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia.
    Dargelos E; Poussard S; Brulé C; Daury L; Cottin P
    Biochimie; 2008 Feb; 90(2):359-68. PubMed ID: 17881114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of soluble calcium-dependent proteolytic activity in brain.
    Baudry M; Simonson L; Dubrin R; Lynch G
    J Neurobiol; 1986 Jan; 17(1):15-28. PubMed ID: 3014063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation.
    Fernández-Montalván A; Assfalg-Machleidt I; Pfeiler D; Fritz H; Jochum M; Machleidt W
    Biol Chem; 2006 May; 387(5):617-27. PubMed ID: 16740134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of the active-site-mutated recombinant human mu-calpain expressed in baculovirus-infected insect cells.
    Hitomi K; Uchiyama Y; Ohkubo I; Kunimatsu M; Sasaki M; Maki M
    Biochem Biophys Res Commun; 1998 May; 246(3):681-5. PubMed ID: 9618272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of calpains, calpastatin and spectrin cleavage in the brain during the pathology of fatal murine cerebral malaria.
    Shukla M; Rajgopal Y; Babu PP
    Neurochem Int; 2006 Jan; 48(2):108-13. PubMed ID: 16236382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle.
    Murphy RM; Verburg E; Lamb GD
    J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myristoyl-coA:protein N-myristoyltransferase from bovine cardiac muscle: molecular cloning, kinetic analysis, and in vitro proteolytic cleavage by m-calpain.
    Raju RV; Kakkar R; Datla RS; Radhi J; Sharma RK
    Exp Cell Res; 1998 May; 241(1):23-35. PubMed ID: 9633510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation of human platelet calpain-I.
    Ariyoshi H; Shiba E; Sakon M; Kambayashi J; Yoshida K; Kawashima S; Mori T
    Biochem Mol Biol Int; 1993 May; 30(1):63-72. PubMed ID: 8358337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.